Par Drugs & Chemicals Ltd.
Closed
BSE SME
SME
Live Chart
| Category | Subscription | Shares Offered | % of Total | Amount (₹Cr) |
|---|---|---|---|---|
|
QIB
|
Over 1.00x
|
— | — | — |
|
NII / HNI
|
Over 1.00x
|
— | — | — |
|
Retail
|
Over 1.00x
|
— | — | — |
| Total | 1.00x | — |
100% | — |
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min — 2 Lots) | 2 | 4,000 | ₹204,000 |
| Retail (Max — 13 Lots) | 13 | 26,000 | ₹1,326,000 |
| S-HNI (Min — 14 Lots) | 14 | 28,000 | ₹1,428,000 |
| B-HNI (Min — 68 Lots) | 68 | 136,000 | ₹6,936,000 |
Par Drugs & Chemicals Ltd. is proposing an IPO on BSE SME under the SME category.
Opens 03 May 2019, closes 08 May 2019. Listing: 16 May 2019. Apply via ASBA or UPI.
| Particulars | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Revenue from Operations | N/A | N/A | N/A |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | N/A | N/A | N/A |
| Net Worth | N/A | N/A | N/A |
| Total Assets | N/A | N/A | N/A |
| Reserves & Surplus | N/A | N/A | N/A |
| Borrowings | N/A | N/A | N/A |
| EBITDA Margin (%) | N/A | — | — |
| PAT Margin (%) | N/A | — | — |
Par Drugs & Chemicals Ltd. IPO is subscribed 1.00 times by May 08, 2019. Retail: 1.00x. QIB: 1.00x. NII: 1.00x.
| Investor Category | Subscription |
|---|---|
| Qualified Institutional (QIB) | 1.00x |
| Non Institutional (NII/HNI) | 1.00x |
| Retail Individual | 1.00x |
| Total Subscription | 1.00x |
The Par Drugs & Chemicals Ltd. IPO retail category is subscribed 1.00 times as of 08 May 2019. The retail portion is oversubscribed.
Subscribe via your broker app using ASBA or UPI. Opens 03 May 2019 and closes 08 May 2019. Min investment: ₹102,000 (1 lot = 2,000 shares). UPI mandate: 5:00 PM on 08 May 2019.
The Par Drugs & Chemicals Ltd. IPO subscribed 1.00x overall. QIB: 1.00x, NII: 1.00x, Retail: 1.00x. Applications: from NSE/BSE.
Check allotment on the registrar website. Enter your PAN, application number or DP/Client ID. Allotment date: 14 May 2019. Refunds: on 15 May 2019.
The Par Drugs & Chemicals Ltd. IPO listing date is 16 May 2019, Thursday. Listed on: BSE SME. Issue price: ₹51. Estimated listing: ₹51. GMP: NIL.
The Par Drugs & Chemicals Ltd. IPO closes on 08 May 2019, Wednesday. UPI mandate: 5:00 PM on 08 May 2019. Allotment: 14 May 2019. Listing: 16 May 2019.